First Time Loading...

Palla Pharma Ltd
ASX:PAL

Watchlist Manager
Palla Pharma Ltd Logo
Palla Pharma Ltd
ASX:PAL
Watchlist
Price: 0.295 AUD Market Closed
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

PAL Price Targets Summary
Palla Pharma Ltd

Wall Street analysts forecast PAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PAL is 1.02 AUD .

PAL Lowest Forecast
Wall Street Target
Not Available
PAL Average Forecast
Wall Street Target
1.02 AUD
246% Upside
PAL Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
1.02 AUD
246% Upside
Highest
Price Target
Not Available
Palla Pharma Ltd Competitors:
Price Targets
RGEN
Repligen Corp
26% Upside
MRVI
Maravai LifeSciences Holdings Inc
32% Upside
BROOKS
Brooks Laboratories Ltd
50% Downside
SEER
Seer Inc
308% Upside
RGEN
Repligen Corp
26% Upside
MRVI
Maravai LifeSciences Holdings Inc
32% Upside
BROOKS
Brooks Laboratories Ltd
50% Downside
SEER
Seer Inc
308% Upside
CRL
Charles River Laboratories International Inc
21% Upside
G
688046
GemPharmatech Co Ltd
90% Upside
B
086040
Biotoxtech Co Ltd
176% Upside
SYNGENE
Syngene International Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
Palla Pharma Ltd

For the last 8 years the compound annual growth rate for Palla Pharma Ltd's revenue is 11%. The projected CAGR for the next 1 year is 98%.

11%
Past Growth
98%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Palla Pharma Ltd

Operating Income forecast
is not available for
Palla Pharma Ltd

Net Income
Forecast

Net Income Estimate
Palla Pharma Ltd

Net Income forecast
is not available for
Palla Pharma Ltd

See Also

Summary
PAL intrinsic value, competitors valuation, and company profile.
DCF Valuation
PAL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PAL stock valuation using valuation multiples.
Wall Street Estimates
PAL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PAL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PAL's stock price target?
Price Target
1.02 AUD

According to Wall Street analysts, the average 1-year price target for PAL is 1.02 AUD .

What is Palla Pharma Ltd's Revenue forecast?
Projected CAGR
98%

For the last 8 years the compound annual growth rate for Palla Pharma Ltd's revenue is 11%. The projected CAGR for the next 1 year is 98%.

ALPHA SPREAD
Join more than 131,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.